Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Clinical trial NCT05022784 · COMPLETED

Trial details

NCT number: NCT05022784
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2021-08-23
Primary completion: 2021-12-30
Enrollment: 1798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.